Orris

Complete respiratory acidosis chapter

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have rich content from multiple authoritative textbooks. Let me compile the complete chapter.

Respiratory Acidosis - Complete Chapter

Definition

Respiratory acidosis is a primary acid-base disorder characterized by an increase in arterial PCO2 (hypercapnia) leading to a fall in arterial pH (acidemia). It results from reduced alveolar ventilation, which causes CO2 retention. The core blood gas profile is:
ParameterDirectionValue
pH↓< 7.35
PaCO2↑ (primary disturbance)> 45 mm Hg
HCO3-↑ (compensatory)Elevated

Pathophysiology

Generation

Alveolar hypoventilation reduces the rate at which CO2 is exhaled. CO2 accumulates in the blood and, via the carbonic anhydrase reaction, drives equilibrium toward H+ production:
CO2 + H2O ⇌ H2CO3 ⇌ H+ + HCO3-
By the Henderson-Hasselbalch equation:
pH = pKa + log [HCO3-] / (α × PCO2)
A rise in PCO2, with HCO3- initially unchanged, causes pH to fall. By mass action, the rise in PCO2 also causes a small rise in HCO3-. - Costanzo Physiology, p. 339

Ventilatory Chemoreceptor Response

There is no respiratory compensation for respiratory acidosis - the respiratory system is itself the cause of the disorder. Central chemoreceptors (in the medulla) account for 65-80% of the integrated ventilatory response to respiratory acidosis under normoxic conditions. Peripheral chemoreceptors (carotid and aortic bodies) respond more rapidly but contribute less. Hypoxia, if coexistent, increases the sensitivity of both peripheral and central chemoreceptors to CO2, accentuating the ventilatory drive. - Medical Physiology, p. 1069

CSF Buffering in Chronic Hypercapnia

In chronic hypercapnia, CSF pH slowly recovers over 8-24 hours via increased HCO3- flux into the CSF/brain extracellular fluid across the choroid plexus and blood-brain barrier. This metabolic compensation to chronic respiratory acidosis shifts the CO2 ventilatory response curve to the right - a higher PaCO2 is needed to produce the same ventilatory response, which explains the blunted CO2 drive seen in long-standing hypercapnia. - Medical Physiology, p. 1070

Compensatory Responses

Immediate (Minutes): Cellular Buffering

CO2 diffuses rapidly across cell membranes. Inside cells (especially red blood cells), it is converted to H+ and HCO3-. The H+ is buffered by intracellular proteins (hemoglobin) and organic phosphates. This is an immediate but limited response. - Costanzo Physiology, p. 339

Acute (Minutes to Hours): Cellular Buffer Phase

The small initial rise in HCO3- is almost entirely from cellular buffering. For every 10 mm Hg rise in PaCO2:
Δ HCO3- = 1 mEq/L (acute buffering)
This means the expected formula:
ΔHCO3- = ΔPaCO2 × 0.1
  • Sabiston Textbook of Surgery, p. 187

Chronic (>24-48 hours): Renal Compensation

The kidneys are the primary compensatory mechanism and take 3-5 days to reach a new steady state:
  • Increased H+ excretion as titratable acid and NH4+ in urine
  • Increased synthesis and reabsorption of new HCO3- in the proximal tubule
  • HCO3- rises approximately 4 mEq/L for every 10 mm Hg rise in PaCO2
ΔHCO3- = ΔPaCO2 × 0.4
The serum bicarbonate concentration typically does not exceed 38 mEq/L, even in severe chronic respiratory acidosis. - Brenner & Rector's The Kidney, p. 707; Sabiston Textbook of Surgery, p. 187
The HCO3- level reaches its peak after approximately 5 days of sustained hypercapnia. Chronic respiratory acidosis may also down-regulate the apical HCO3-/Cl- exchanger pendrin in the distal tubule, reducing HCO3- loss. - Murray & Nadel's Textbook of Respiratory Medicine, p. 275
Once the new steady state is reached, H+ secretion by the kidney returns to normal (just enough to reabsorb the elevated filtered HCO3-), and NH4+ and titratable acid excretion normalize. - Murray & Nadel's Textbook of Respiratory Medicine, p. 275

Summary of Compensation Rules

TypeFormulapH change
AcuteΔHCO3- = ΔPaCO2 × 0.1 (or +1 mEq/L per 10 mmHg ↑ PaCO2)Greater fall
ChronicΔHCO3- = ΔPaCO2 × 0.4 (or +4 mEq/L per 10 mmHg ↑ PaCO2)Partially corrected

Causes

Respiratory acidosis results from any condition that impairs alveolar ventilation. Causes are organized by the anatomical level affected:

1. Depression of the Respiratory Center (CNS)

  • Acute: General anesthetics, sedatives (benzodiazepines, barbiturates), opioids/narcotics, alcohol, head trauma
  • Chronic: Sedatives, alcohol, intracranial tumors, primary alveolar hypoventilation (Ondine's curse), obesity-hypoventilation syndrome (Pickwickian syndrome), central sleep apnea
  • Oxygen therapy in severe chronic CO2 retainers (removes hypoxic drive)

2. Neuromuscular Disorders

  • Guillain-Barré syndrome
  • Poliomyelitis
  • Amyotrophic lateral sclerosis (ALS)
  • Multiple sclerosis
  • Myasthenia gravis
  • Electrolyte disorders (hypokalemia, hypophosphatemia)
  • Drugs (aminoglycosides, organophosphates)

3. Airway Obstruction

  • Aspiration of foreign body or vomitus
  • Obstructive sleep apnea
  • Laryngospasm
  • Severe acute asthma/anaphylaxis
  • Inhalational burn or toxin injury

4. Parenchymal / Gas Exchange Disorders

  • Acute: ARDS, pneumonia, pulmonary edema, severe acute asthma
  • Chronic/End-stage: COPD (most common cause of chronic respiratory acidosis), end-stage pulmonary fibrosis
  • Restrictive lung disease (chest wall or lung): ventilatory muscle fatigue from high work of breathing causes chronic respiratory acidosis in advanced stages

5. Mechanical Ventilation (Iatrogenic)

  • Inadequate settings (insufficient tidal volume or respiratory rate)
  • Barotrauma or endotracheal tube displacement
  • High PEEP with reduced cardiac output (increased dead-space ventilation)
  • Rising CO2 production in a patient on fixed ventilation (fever, agitation, sepsis, overfeeding)

6. Surgical/Abdominal Causes (Schwartz's Principles)

  • Significant secretions, atelectasis, mucus plugs, pneumonia, pleural effusion
  • Pain from abdominal/thoracic incisions limiting respiratory effort
  • Abdominal distension, compartment syndrome, ascites (limiting diaphragmatic excursion)
  • Narcotics (post-operative)
  • Schwartz's Principles of Surgery, p. 129; Brenner & Rector's The Kidney, p. 707; Costanzo Physiology, p. 339

Clinical Features

The severity of manifestations depends on the rate of onset, severity of hypercapnia, and presence of coexisting hypoxemia.

Neurological (Hypercapnic Encephalopathy - "CO2 Narcosis")

Rapid increases in PaCO2 cause:
  • Anxiety, dyspnea, restlessness
  • Confusion, disorientation, psychosis, hallucinations
  • Headache (CO2 is a potent cerebral vasodilator)
  • Signs mimicking raised intracranial pressure: papilledema, abnormal reflexes, focal muscle weakness
  • Progression to coma (CO2 narcosis) and respiratory arrest if untreated
Chronic/subacute hypercapnia may cause more subtle features:
  • Sleep disturbances
  • Loss of memory, daytime somnolence, personality changes
  • Coordination impairment
  • Tremor, myoclonic jerks, asterixis (flapping tremor, as also seen in hepatic encephalopathy)

Cardiovascular

  • Peripheral vasodilation (CO2 is a direct vasodilator) - warm, flushed skin
  • Tachycardia, hypertension (from catecholamine release due to hypercapnia and hypoxemia)
  • Severe acidemia can cause cardiac arrhythmias and myocardial depression

Respiratory

  • Dyspnea, tachypnea (or bradypnea/apnea in CNS depression)
  • Pursed-lip breathing, use of accessory muscles
  • Cyanosis (if significant hypoxemia is also present)
  • Brenner & Rector's The Kidney, p. 707

Diagnosis

Arterial Blood Gas (ABG) - Required

Diagnosis requires measurement of PaCO2 and arterial pH. ABG findings:
  • pH < 7.35
  • PaCO2 > 45 mm Hg
  • HCO3- elevated (degree indicates acute vs. chronic)

Distinguishing Acute from Chronic

This distinction is clinically critical - acute respiratory acidosis can progress rapidly to respiratory arrest, while chronic is more stable but harder to correct.
FeatureAcuteChronic
HCO3- rise per 10 mmHg ↑ PaCO2~1 mEq/L~4 mEq/L
pHMore depressedPartially corrected
Clinical historySudden onsetLong-standing lung disease, COPD
HCO3- levelNear normal (~25-26)Elevated (28-38)
Clinical Pearls:
  • A patient with COPD and PCO2 of 70 mm Hg (ΔPaCO2 = 30) should have HCO3- ~36 if fully compensated chronically (30 × 0.4 + 24 = 36). If HCO3- is only ~27 (Δ3 mEq/L ≈ acute rule), this suggests acute decompensation on a chronic background.
  • Always look for a superimposed metabolic acidosis (e.g., lactic acidosis from hypoxia) - the anion gap should be calculated. - Costanzo Physiology, p. 339

Workup for Underlying Cause

  • Chest X-ray: First imaging step
  • Pulmonary function tests: Spirometry, diffusion capacity, lung volumes, PaCO2/O2 saturation - assess if respiratory acidosis is lung-origin
  • Drug history: Rule out sedatives, opioids, other respiratory depressants
  • Hematocrit: Assess for anemia contributing to tissue hypoxia
  • Upper airway assessment: Rule out obstruction
  • Neuromuscular assessment: Chest wall and respiratory muscle function
  • Electrolytes: Rule out electrolyte disorders causing neuromuscular weakness (hypokalemia, hypophosphatemia)
  • Brenner & Rector's The Kidney, p. 708; Harrison's Principles of Internal Medicine 22e

Treatment

Treatment targets both the underlying cause and restoration of adequate ventilation. The approach differs based on acuity and severity.

1. Acute Respiratory Acidosis (Life-Threatening Priority)

Acute respiratory acidosis is a medical emergency. Measures to reverse the underlying cause and restore ventilation must be undertaken simultaneously:
  • Airway management: If severe or rapidly worsening - tracheal intubation and assisted mechanical ventilation
  • Non-invasive ventilation (NIV): Bilevel positive airway pressure (BiPAP) can be used for patient-initiated volume expansion before intubation is required - particularly useful in COPD exacerbations
  • Targeted therapy: Reverse opioid toxicity with naloxone; treat severe bronchospasm with bronchodilators; treat pneumonia with antibiotics, etc.

2. Oxygen Therapy - Use with Caution

In severe chronic COPD patients with chronic CO2 retention who are breathing spontaneously:
  • These patients may rely on hypoxic drive (PaO2) for ventilation, since their central chemoreceptors are blunted to chronically elevated CO2
  • Injudicious high-flow oxygen can remove this hypoxic drive, causing respiratory drive suppression, worsening hypoventilation, and progressive severe acidemia
  • Oxygen should be carefully titrated, targeting SaO2 of approximately 88-92%
  • Harrison's Principles of Internal Medicine 22e; Brenner & Rector's The Kidney, p. 708

3. Avoid Rapid Correction of Hypercapnia

Aggressive, rapid reduction of PaCO2 should be avoided because:
  • The brain and kidneys have adapted to chronic hypercapnia by retaining HCO3-
  • Rapid fall in PaCO2 (without time for renal HCO3- excretion) produces post-hypercapnic metabolic alkalosis
  • This alkalosis may cause: cardiac arrhythmias, reduced cerebral perfusion (cerebral vasoconstriction), and seizures
  • Target: Lower PaCO2 gradually back to the patient's baseline
  • Harrison's Principles of Internal Medicine 22e

4. Correction of Electrolytes

When lowering PaCO2 in chronic respiratory acidosis:
  • Provide adequate Cl- and K+ to facilitate renal excretion of the elevated HCO3-
  • Without sufficient chloride and potassium, the kidneys cannot excrete the excess bicarbonate, and post-hypercapnic alkalosis will develop/persist
  • Harrison's Principles of Internal Medicine 22e; Brenner & Rector's The Kidney, p. 708

5. Bicarbonate Administration

  • Generally not indicated as primary therapy for respiratory acidosis (does not address the underlying problem and further raises PaCO2 when CO2 is liberated from NaHCO3, especially dangerous in patients on fixed-rate ventilation)
  • May be considered in mixed respiratory + metabolic acidosis (e.g., severe lactic acidosis superimposed on ARDS with permissive hypercapnia)
  • If used, the goal is not to normalize pH/HCO3- but to reduce the severity of acidemia. Target arterial pH ≈ 7.25
  • Requires frequent monitoring of ABGs, electrolytes, and volume status
  • Brenner & Rector's The Kidney, p. 707

6. Permissive Hypercapnia

In mechanically ventilated patients with ARDS:
  • Low tidal volume (lung-protective) ventilation is the standard of care to reduce barotrauma
  • This strategy deliberately accepts elevated PaCO2 (permissive hypercapnia) as a trade-off
  • The resulting acidosis is less severe when CO2 is allowed to rise gradually
  • A reasonable target pH ≈ 7.25 is acceptable
  • Caution: if permissive hypercapnia is superimposed on metabolic acidosis (e.g., lactic acidosis), the combined acidemia can be severe and life-threatening
  • Brenner & Rector's The Kidney, p. 707

7. Management of Chronic Respiratory Acidosis

Chronic respiratory acidosis is frequently difficult to correct. General measures include:
  • Smoking cessation
  • Long-term oxygen therapy (appropriately titrated)
  • Bronchodilators (beta-agonists, anticholinergics in COPD)
  • Corticosteroids (in inflammatory airways disease)
  • Diuretics (if cor pulmonale/fluid overload)
  • Chest physiotherapy / pulmonary rehabilitation
  • Management of sleep-disordered breathing (CPAP, BiPAP)
  • Respiratory stimulants (e.g., medroxyprogesterone in obesity-hypoventilation) - rarely used today
  • Brenner & Rector's The Kidney, p. 708

Key Clinical Scenario: COPD Exacerbation

A 68-year-old, 3 pack-year smoker presents with cough, fever, dyspnea, cyanosis, barrel-shaped chest, and wheezing. ABG: pH 7.29, PCO2 70 mm Hg, PO2 54 mm Hg, HCO3- 33 mEq/L. Na+ 139, Cl- 95.
Analysis:
  1. pH 7.29 - acidemia
  2. PCO2 70 mm Hg - elevated (respiratory acidosis is primary)
  3. HCO3- 33 mEq/L - elevated (compensatory)
  4. ΔPaCO2 = 30 mm Hg
    • Acute rule: expected ΔHCO3- = 30 × 0.1 = 3 mEq/L → HCO3- would be ~27
    • Chronic rule: expected ΔHCO3- = 30 × 0.4 = 12 mEq/L → HCO3- would be ~36
    • Actual ΔHCO3- = 9 mEq/L → closer to chronic (but not fully compensated)
  5. Anion gap = 139 - 95 - 33 = 11 (normal) → no significant superimposed anion-gap metabolic acidosis yet; monitor for developing lactic acidosis given low PO2
Conclusion: Chronic respiratory acidosis (COPD) with possible early acute decompensation. Management: antibiotics, controlled low-flow oxygen, BiPAP. Avoid rapid correction; watch for lactic acidosis. - Costanzo Physiology, p. 339-340

Summary Table

FeatureAcute Respiratory AcidosisChronic Respiratory Acidosis
Primary disturbance↑ PaCO2↑ PaCO2
pHMarkedly ↓Mildly ↓ or near normal
HCO3- compensation+1 mEq/L per 10 mmHg ↑ PCO2+4 mEq/L per 10 mmHg ↑ PCO2
Mechanism of compensationCellular buffering (immediate)Renal H+ excretion + new HCO3- synthesis (days)
Time to full compensationMinutes3-5 days
Max HCO3-~26-28 mEq/LUp to 38 mEq/L
Common causesOpioid OD, acute asthma, ARDS, airway obstructionCOPD, obesity-hypoventilation, neuromuscular disease
UrgencyEmergency - risk of respiratory arrestChronic management
Key treatmentAirway/ventilation, treat causeOptimize lung function, avoid rapid PCO2 correction
Sources:
  • Brenner & Rector's The Kidney, pp. 707-708
  • Costanzo Physiology 7th Edition, pp. 338-340
  • Harrison's Principles of Internal Medicine 22e, p. 419
  • Murray & Nadel's Textbook of Respiratory Medicine, p. 275
  • Sabiston Textbook of Surgery, p. 187
  • Schwartz's Principles of Surgery 11th Edition, p. 129
  • Medical Physiology (Boron & Boulpaep), pp. 1069-1070
  • Symptom to Diagnosis: An Evidence-Based Guide, 4th Edition, p. 6065
This is a shared conversation. Sign in to Orris to start your own chat.